Abiopharma

Perion Launches New Advanced Features for Programmatic Digital Out of Home at WOO London 2026

FibroBiologics Announces First Patients Dosed in Phase 1/2 Clinical Trial Evaluating CYWC628 for the Treatment of Diabetic Foot Ulcers

Cabaletta Bio Announces New Rese-cel Data and Development Updates Across Autoimmune Portfolio, Including Encouraging Early PC-Free Lupus Findings, at EULAR 2026 Congress

VERSABANK ANNOUNCES PUBLIC FILING OF FORM S-4 REGISTRATION STATEMENT WITH THE SEC

FactSet Schedules Third Quarter 2026 Earnings Call

Axsome Therapeutics Announces Settlement Resolving All SUNOSI® (solriamfetol) Patent Litigation

BrilliA Incorporated Announces Jockey® Trademark License Agreement for Indonesia

NIQ Named 2026 Retail & Consumer Goods Snowflake Product Partner of the Year

Accel Entertainment Expands Louisiana Presence With Acquisition of Rice Palace Truck Stop Casino

Old Dominion Freight Line Provides Update for Second Quarter 2026